This inventor holds 3 USPTO granted patents. Top assignees: University of California, Regents of the University of Minnesota. Active years: 2017-2026.
Location History:
- San Clemente, CA (US) (2017)
- La Jolla, CA (US) (2022)
Company Filing History:
3 out of 16,008 
1 out of 2,369 
Years Active: 2017-2026
Title: Rommie E Amaro: Innovator in Cancer Treatment
Introduction
Rommie E Amaro is a notable inventor based in San Clemente, CA (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of pharmaceutical compounds. With a total of 3 patents, Amaro's work focuses on advancing medical science and improving therapeutic options for patients.
Latest Patents
Among his latest patents, Amaro has developed compounds that degrade kinases and their uses. This patent discloses compounds of specific formulas that include Aurora A ligands and CDK4/6 ligands, along with E3 ligase ligands. These compounds are designed for pharmaceutical compositions aimed at treating cancer. Another significant patent involves PI3Kγ inhibitors, which relate to methods of using these inhibitors in therapeutic applications.
Career Highlights
Throughout his career, Rommie E Amaro has worked with prestigious institutions such as the University of California and the Regents of the University of Minnesota. His research has been pivotal in the development of new cancer therapies, showcasing his commitment to advancing medical knowledge and treatment options.
Collaborations
Amaro has collaborated with esteemed colleagues, including Ozlem Demir and Daniel A Harki. These partnerships have further enriched his research and contributed to the success of his innovative projects.
Conclusion
Rommie E Amaro stands out as a dedicated inventor whose work in cancer treatment has the potential to make a significant impact on patient care. His innovative patents and collaborations reflect his commitment to advancing medical science.